Mandaviya inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in Indore

Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh

Merck announces Phase 3 trial initiations for 4 Investigational Candidates from hematology and oncology pipeline

Comprehensive clinical development programs being initiated for each investigational candidate

Hyderabad to host 66th All India Congress of Obstetrics and Gynaecology 2024

The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology

PayNearby, Star Health join forces to provide health cover to uninsured across Bharat

Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors

CCRAS launches ‘SMART 2.0’ for ayurveda teaching professionals

Medway Hospitals raises US$5 million in a financing round led by Kyra Ventures

Medway setup a state-of-the-art Heart Institute in Chennai

Mandaviya lays foundation stone for NCDC regional branch, state branches and 2 BSL-3 laboratories

Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation

Dr. Reddy's acquires MenoLabs

Cell and gene therapy will be top industry trend for pharma in 2024, finds GlobalData

The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year

Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171 mn

Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)